PE Anti-Human IL-21 Antibody [3A3-N2] (AGEL2051)

PE Anti-Human IL-21 Antibody [3A3-N2]

The Human IL-21 Monoclonal Antibody PE-Conjugated (3A3-N2) is a vital tool for researchers investigating the functions of interleukin-21 (IL-21) in immune responses and diseases. This antibody, conjugated with phycoerythrin (PE) for fluorescence-based applications, specifically targets IL-21, a cytokine with diverse roles in the immune system.IL-21 is known for its involvement in regulating immune responses, particularly in promoting B and T cell differentiation and function. Its dysregulation has been linked to various immune-related disorders, including autoimmune diseases and inflammatory conditions.

The PE-conjugated monoclonal antibody 3A3-N2 recognizes IL-21 with high specificity, allowing for precise detection and analysis of this key cytokine in experimental settings.By utilizing this antibody, researchers can explore the intricate mechanisms by which IL-21 impacts immune cell activities and disease processes. From investigating the therapeutic potential of IL-21 modulation to uncovering its role in immune-mediated pathologies, this antibody provides a valuable tool for advancing our understanding of immune regulation and potential treatment strategies.

Isotype:	Mouse IgG1, κ
Isotype Control:	PE Mouse IgG1, κ Isotype Control[MOPC-21]
Form:	Liquid
Conjugation:	PE
Recommended Use:	Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Spectrum: